Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Penumbra Inc (PEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,620,976
  • Shares Outstanding, K 34,653
  • Annual Sales, $ 444,940 K
  • Annual Income, $ 6,600 K
  • 60-Month Beta 0.80
  • Price/Sales 10.19
  • Price/Cash Flow 184.27
  • Price/Book 10.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.17
  • Number of Estimates 2
  • High Estimate 0.22
  • Low Estimate 0.12
  • Prior Year 0.06
  • Growth Rate Est. (year over year) +183.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
122.40 +8.95%
on 04/17/19
159.82 -16.56%
on 03/26/19
-24.61 (-15.58%)
since 03/22/19
3-Month
122.40 +8.95%
on 04/17/19
162.50 -17.94%
on 03/22/19
-5.35 (-3.86%)
since 01/24/19
52-Week
110.84 +20.31%
on 12/24/18
167.35 -20.32%
on 06/01/18
+12.75 (+10.57%)
since 04/24/18

Most Recent Stories

More News
Intuitive Surgical (ISRG) Q1 Earnings, Revenues Lag Estimates

Intuitive Surgical's (ISRG) Q1 results outside the United States impress.

WMGI : 29.05 (+0.83%)
PEN : 133.35 (+1.91%)
MASI : 126.78 (-0.24%)
ISRG : 508.14 (+1.54%)
Edwards Lifesciences Takes Over CAS Medical Systems for $100M

This CASMED acquisition is expected to strengthen Edwards Lifesciences' (EW) critical care portfolio and expand its footprint in the smart monitoring technology market.

EW : 177.73 (-1.80%)
AMED : 123.58 (-0.23%)
VAR : 133.27 (+0.27%)
PEN : 133.35 (+1.91%)
Here's Why You Should Invest in Chemed (CHE) Stock Right Now

Chemed (CHE) is expected to benefit from the launch of its VITAS Healthcare Inpatient Hospice Unit.

CHE : 327.45 (+0.50%)
AMED : 123.58 (-0.23%)
VAR : 133.27 (+0.27%)
PEN : 133.35 (+1.91%)
Penumbra, Inc. Schedules First Quarter 2019 Earnings Release and Conference Call for May 7, 2019

Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2019 after market close on Tuesday, May 7, 2019 at 4:30 PM Eastern Time....

PEN : 133.35 (+1.91%)
Medidata Launches Acorn Artificial Intelligence Company

Driven by Medidata's (MDSO) standardized clinical data storehouse, and operating on its pioneering platform, Acorn AI is set to become one of the premier AI companies in the field of life sciences.

AMED : 123.58 (-0.23%)
VAR : 133.27 (+0.27%)
MDSO : 89.62 (+2.20%)
PEN : 133.35 (+1.91%)
Stryker's LIFEPAK CR2 Defibrillator Launch to Boost MedSurg

Stryker's (SYK) emergency care department offers a broad range of products and systems.

WMGI : 29.05 (+0.83%)
SYK : 185.04 (-1.03%)
PEN : 133.35 (+1.91%)
MASI : 126.78 (-0.24%)
Here's Why You Should Buy Masimo (MASI) Stock Right Now

Masimo (MASI) has been benefitting from developments like the FDA clearance of the Rad-67 Pulse CO-Oximeter.

WMGI : 29.05 (+0.83%)
VAR : 133.27 (+0.27%)
PEN : 133.35 (+1.91%)
MASI : 126.78 (-0.24%)
Hologic's Diagnostics Grows Strong, Escalating Costs a Woe

To fortify its product portfolio, Hologic (HOLX) is working on innovations and product introductions. On this front, Cynosure's R&D pipeline stays robust.

HOLX : 44.73 (+1.06%)
AMED : 123.58 (-0.23%)
VAR : 133.27 (+0.27%)
PEN : 133.35 (+1.91%)
ResMed Launches AirFit P30i Nasal Pillows Mask in the US

ResMed (RMD) to expand its portfolio of sleep apnea devices on the back of AirFit P30i nasal pillows mask.

AMED : 123.58 (-0.23%)
VAR : 133.27 (+0.27%)
PEN : 133.35 (+1.91%)
RMD : 101.73 (+0.24%)
Medtronic's (MDT) Study Shows Positive Results of TDD Use (revised)

The outcomes of the study demonstrates that patients on TDD along with CMM witnessed some major benefits compared to those on CMM alone.

SYK : 185.04 (-1.03%)
AMED : 123.58 (-0.23%)
PEN : 133.35 (+1.91%)
MDT : 85.64 (+0.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators mostly agree with the trend.

See More Share

Trade PEN with:

Business Summary

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access...

See More

Key Turning Points

2nd Resistance Point 139.59
1st Resistance Point 136.47
Last Price 133.35
1st Support Level 130.23
2nd Support Level 127.11

See More

52-Week High 167.35
Fibonacci 61.8% 145.76
Fibonacci 50% 139.10
Last Price 133.35
Fibonacci 38.2% 132.43
52-Week Low 110.84

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar